LobbyingLincoln Therapeutics lobbying by quarter
Lincoln Therapeutics's latest lobbying report covers Q4 2024, at $10K. Its first report covers Q1 2023; the issues it reports most are Budget/Appropriations and Defense.
Lincoln Therapeutics
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $0 | 1 |
| Q2 2023 | $40K | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $30K | 1 |
| Q2 2024 | $10K | 1 |
| Q3 2024 | $10K | 1 |
| Q4 2024 | $10K | 1 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Budget and appropriations8 reports
- Defense8 reports
- Health issues8 reports
A report that names several issues counts once for each.
Who was lobbied
- SENATE8 reports
- HOUSE OF REPRESENTATIVES5 reports
Firms it paid
| Firm | ||
|---|---|---|
| McAllister & Quinn | $100K | 8 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ANDREW QUINN | SA, LA - Rep. Hoyer | Q4 2024 |
| ELIZABETH FOLEY | LA - Rep. McCollum | Q4 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/01/21for Q4 2024 | McAllister & Quinn | $10K |
| 24/10/16for Q3 2024 | McAllister & Quinn | $10K |
| 24/07/19for Q2 2024 | McAllister & Quinn | $10K |
| 24/04/15for Q1 2024 | McAllister & Quinn | $30K |
| 24/01/17for Q4 2023 | McAllister & Quinn | Under $5,000 |
| 23/10/18for Q3 2023 | McAllister & Quinn | Under $5,000 |
| 23/07/12for Q2 2023 | McAllister & Quinn | $40K |
| 23/04/19for Q1 2023 | McAllister & Quinn | Under $5,000 |
| 23/04/17for Q1 2023 | McAllister & Quinn | Under $5,000 |